RSS Feed

A Nightmarish Week For Boeing's Dreamliner

With brake issues, fuel leaks and a battery fire in three separate incidents, it has not been a good week for the Boeing Dreamliner. Host Scott Simon talks with New York Times op-ed columnist Joe Nocera about troubles that have beset the new Boeing 787 this past week.

Why Are Investors In Like With Facebook Again?

Facebook's stock sank after its initial public offering last May. But since the new year began, its share price has soared nearly 20 percent. Is this the year it finally figures out how to make money from mobile users? There's lots of speculation about what it might announce next Tuesday.

Cigarette Makers Frustrated As Product Approvals Stall

The Food and Drug Administration must review all new tobacco brands, and changes to existing ones, under a 2009 law giving the agency jurisdiction over tobacco. But the FDA has yet to approve any products under the new system, leaving some cigarette makers frustrated with the pace.

Businesses Sue Government Over Birth Control Mandate

Religious groups were among the first to object to a requirement that employers' health plans provide free birth control. But some companies have also objected, saying the mandate violates their religious freedom, too.

FAA To Review New 787 Dreamliner After Spate Of Problems

Boeing faces a comprehensive review of the design and manufacturing of its ballyhooed 787 Dreamliner.

Hedge Fund Titans Bet Billions On Success Or Failure Of 'Herbalife'

A pair of prominent hedge fund managers have taken opposing positions on the nutritional-supplement company Herbalife. Bill Ackman of Pershing Square Capital Management says the multilevel-marketing company is a pyramid scheme and a bad investment. He's shorting the stock. Dan Loeb of hedge fund Third Point says Herbalife is a good investment. He's taken an 8.2 percent stake in the company and is betting that its shares will rise. Melissa Block talks with David Kestenbaum of the Planet Money team.